Raymond James Financial Services Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,675
Closed -$106K 3389
2024
Q1
$106K Buy
+10,675
New +$106K ﹤0.01% 3212